GABA and Dopamine Release from Different Brain Regions in Mice with Chronic
          Exposure to Organophosphate Methamidophos by Noriega-Ortega, Blanca Rosa et al.
J Toxicol Pathol 2011; 24: 163–168
Original
GABA and Dopamine Release from Different Brain Regions 
in Mice with Chronic Exposure to Organophosphate  
Methamidophos
Blanca Rosa Noriega-Ortega1, Ernesto Armienta-Aldana1,  
José Ángel Cervantes-Pompa1, Eduardo Armienta-Aldana2,  
Enrique Hernández-Ruíz3, Verónica Chaparro-Huerta4,  
Alejandro Bravo-Cuellar5, and Carlos Beas-Zárate4,6
1  Facultad de Medicina, Universidad Autónoma de Sinaloa (UAS), Culiacán, Sinaloa, México
2  Facultad de Ciencias Químico-Biológicas, Universidad Autónoma de Sinaloa (UAS), Culiacán, Sinaloa, México
3  Departamento de Farmacología, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara 
(U de G), Guadalajara, Jalisco, México
4  Laboratorio de Neurobiología Celular y Molecular, División de Neurociencias, Centro de Investigación Biomédica de 
Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara, Jalisco, México
5  Laboratorio de Inmunología de los Tumores, División de Inmunología, Centro de Investigación Biomédica de Occi-
dente (CIBO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara, Jalisco, México
6  Departamento de Biología Celular y Molecular, Centro Universitario de Ciencias Biológicas y Agropecuarias (CUC-
BA), Universidad de Guadalajara (U de G), Guadalajara, Jalisco México
Abstract:	 Organophosphates	such	as	methamidophos,	usually	used	in	the	agricultural	field,	have	harmful	effects	on	
humans. Exposures to insecticides has been associated with many disorders, including damage to the central and pe-
ripheral nervous system. Chronic exposure to organophosphates may lead to persistent neurological and neurobehav-
ioral	effects.	This	study	was	conducted	to	determine	the	effect	of	methamidophos	on	[3H]-dopamine (DA) and gamma 
aminobutyric	acid	(GABA)	release	from	different	brain	regions	after	chronic	exposure	to	it	for	3,	6	or	9	months.	After	
a six-month methamidophos treatment, the mice showed high susceptibility to convulsive seizures and a reduction in 
stimulated	gamma	aminobutyric	acid	release	from	the	cerebral	cortex	and	hippocampal	slices,	whereas	stimulated	(DA)	
release	was	slightly	decreased	from	the	striatum	after	three	months	of	methamidophos	exposure.	The	results	indicate	
changes	in	gamma	aminobutyric	acid	and	dopamine	neurotransmission,	suggesting	a	specific	neuronal	damage.	(DOI:	
10.1293/tox.24.163;	J	Toxicol	Pathol	2011;	24:	163–168)
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Introduction
Insecticides are essential to the human population in 
terms	of	food	security	and	disease	prevention.	There	has	
been	an	increase	in	the	use	of	insecticides,	but	the	pests	
themselves have become more resistant and, consequently, 
the	tolerated	minimum	dose	has	increased	(it	can	range	from	
a	few	grams),	causing	health	problems.	The	mechanism	of	
action	is	by	inhibition	of	the	enzyme	acetylcholinesterase	
(AChE)	and	formation	of	acetylcholine	(ACh)	with	its	con-
sequent	alterations	of	the	central	nervous	system,	affecting	
the cholinergic neurotransmission in the peripheral and cen-
tral nervous system1,2.	The	spectrum	of	effects	caused	by	
excess	ACh	depends	upon	the	distribution	of	the	insecticide	
in the body and the receptor type with which ACh interacts3.
On the other hand, neurotoxic and schizophrenic re-
actions, depression, and damage to memory with thought 
difficulties	have	been	observed	in	groups	of	workers	ex-
posed	to	different	insecticides4.	That	damage	can	persist	for	
some months with neuropathologic injuries and cognosci-
tive	and	neuromuscular	function	damage	with	symptoms	of	
ataxia,	convulsions,	parestesia	and	defects	in	speech,	lack	
of	memory,	insomnia	and	mental	disorder5. Exposure to or-
ganophosphates may produce neuropsychiatric symptoms 
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and biochemical alterations in humans, such as anxiety, 
depression,	impairment	of	concentration	and	learning,	fa-
tigue,	postural	instability	and	rigidity	of	face	muscles,	bra-
dykynesia	and	transient	parkinsonism6. Exposure to phos-
phorated	insecticides	for	a	long	time	results	in	convulsions,	
respiratory damage and cardiac arrhythmia that can lead to 
cerebral anoxia7.	Comparative	studies	have	been	performed	
on	the	action	of	the	receptor	for	gamma	aminobutyric	acid	
(GABA), N-methyl-D-aspartate (NMDA), and dopamine 
(DA)	release.	With	kainic	acid	administration	by	perfusion	
and	 microdialysis,	 there	 were	 toxic	 signs	 of	 convulsions	
with greater DA, GABA and aspartate release at the stria-
tum8. Gabaergic power stations and neurons, and the num-
ber	of	positive	cells	for	GABA	were	reduced	in	the	brain,	
causing	abnormal	movements	of	the	eyes	in	humans9. Only 
a	few	studies	on	chronic	poisoning	by	phosphorated	insec-
ticides	exist.	This	work	therefore	aimed	to	study	the	effects	
of	GABA	and	DA	release	on	different	brain	regions	of	mice	
after	chronic	exposure	to	a	methamidophos	device.
Materials and Methods
Animals
Forty	adult	male	Balb/c	mice	at	3	months	(12	weeks)	of	
age	and	weighing	22–25	g	were	used.	They	were	kept	un-
der	standard	conditions	with	12-h	light:12-h	dark	cycles	and	
free	access	to	water	and	food	in	polypropylene	cages	with	
controlled	temperature	of	23	±	2	°C	and	relative	humidity	of	
85	±	5	percent.
The	 dose	 of	 insecticide	 to	 which	 the	 experimental	
animals were exposed was determined by a dose-response 
curve.	We	used	several	groups	of	10	mice	to	find	the	median	
lethal dose (LD50)	of	methamidophos	with	different	concen-
trations	following	the	method	of	Miller	and	Tainter10 and de-
termined	the	subacute	or	chronic	exposure	dose,	2.6	mg/kg.
The animals were divided into two groups, one ex-
posed	to	the	insecticide	methamidophos	at	a	dose	of	2.6	mg/
kg	administered	subcutaneously	every	third	day	through-
out	the	duration	of	this	study	(3,	6	and	9	months)	and	the	
other constituting the control group, which was treated with 
physiological	saline	as	the	vehicle	solution.	At	the	end	of	the	
exposure	period,	the	animals	were	sacrificed	by	decapita-
tion.	Their	brains	were	removed,	and	slices	of	the	different	
brain regions (cerebral cortex, striatum, and hippocampus) 
were	dissected	to	perform	the	GABA	and	DA	release	ex-
periments. Tissue slices were immediately washed with a 
0.32	M	sucrose	solution	at	temperatures	ranging	from	0	to	
4	°C.
The experimental methods applied to laboratory ani-
mals used in this investigation 22 were carried out under 
the	guidelines	of	the	Mexican	Official	Standard	NOM-062-
ZOO-	23	1999	backed	by	the	Coordination	of	Research	and	
Ethics	Committee	of	the	Faculty	of	24	Medicine	of	the	Na-
tional	Autonomous	University	of	Mexico	(UNAM).
Materials
Methamidophos (Tamaron 600®)	 formulated	 as	 a	
soluble	liquid	base	of	methamidophos	(O,S-dimethyl	phos-
phoramidothioate)	for	agricultural	use	was	purchased	from	
Bayer Chemical Corporation in Mexico.
Dihydroxyphenylethylamine,	 3,4-[7-3H(N)]-, or tri-
tiated	 [3H]-dopamine	 ([3H]-DA)	 (31	 Ci/mmol)	 and	 γ	
-[2,3-3H(N)]-aminobutyric	 acid	 (-[3H]-GABA)	 (36.8	 Ci/
mmol)	were	purchased	from	New	England	Nuclear,	Wilm-
ington,	DE,	USA.	All	other	reagents	were	from	Sigma-Al-
drich (St. Louis, MO, USA).
[3H]-DA and [3H]-GABA
Release experiments were conducted in accordance 
with	the	following	protocol:	to	measure	the	[3H]-DA baseline 
flow,	a	Krebs-bicarbonate	medium	was	made	with	115	mM	
NaCl,	 3	mM	 KCl,	 1.2	mM	 Mg2SO4, 1.2  mM NaH2PO4, 
25 mM NaHCO3, 1.5 mM CaCl2, 10 mM glucose, 0.1 mM 
ascorbic	acid	and	25	μM	Iproniazide	and	adjusted	to	pH	7.4	
with a CO2-O2	mixture	(5–95%).	For	[ 3H]-GABA, release 
experiments	were	carried	out	as	[3H]-DA release using only 
the incubation medium containing 1 mM aminooxyacetic 
acid to avoid GABA metabolism11.
Slices	of	different	brain	regions	(cerebral	cortex,	hip-
pocampus	and	striatal)	were	incubated	for	20	min	in	1	mL	
of	incubation	medium	for	 GABA	at	37	°C	together	with	
[3H]-DA.	The	samples	were	then	transferred	to	a	filter	per-
fusion	Whatman	GF/B	system.	Both	filters	and	tissue	sam-
ples	were	washed	an	SP-06	Brandel	perfusion	system	at	a	
250-μl	flow	for	30	min.	Three	consecutive	10	min	fractions	
were	then	collected	and	taken	as	the	baseline	flow.	Spon-
taneous release was conducted with a solution containing 
drugs	for	the	following	four	fractions	(40	min)	with	a	10	µM	
concentration	in	all	cases.	Finally,	three	additional	fractions	
were	collected	with	a	baseline	medium.	Every	fraction	was	
collected	in	vials	with	radioactive	fluid,	and	radioactivity	
was	measured	with	a	model	LS6000	Beckman	scintiscan.
Spontaneous	 [3H]-DA release was calculated as the 
amount	of	DA	released	in	the	presence	of	drugs	over	the	
baseline	flow	(read	as	0%).	Results	were	expressed	as	the	
overflow	in	percentage	of	the	total	radioactivity	present	in	
the	samples,	with	fraction	number	6	having	the	greatest	re-
lease value.
Statistical analysis
Statistical	 significance	 between	 group	 means	 was	
found	by	one-way	ANOVA	analysis	using	the	SPSS	comput-
er	program	with	significance	denoted	by	p<0.001–p	<0.05.
Results
Collateral effects of methamidophos treatment
Treatment	 of	 the	 animals	 with	 methamidophos	 pro-
duced	a	significant	body	weight	reduction	at	the	end	of	the	
6-month	period,	and	a	loss	of	25%	was	observed	within	6	
and	9	months	of	treatment	(data	not	shown).	All	animals	Noriega-Ortega, Armienta-Aldana, Cervantes-Pompa et al. 165
showed tonic convulsive seizures characterized by a gen-
eralized	body	tremor;	the	latency	time	was	observed	to	be	
between	7	and	15	min	after	receipt	of	the	methamidophos	
treatment. The convulsive duration was approximately 
20 min, and some aggressive behavior was also observed in 
some	animals	after	5–6	months	of	treatment.	During	acute	
poisoning, it was also observed that the mice had white 
eyes,	spiky	hair	and	sometimes	nosebleed.
Cortical and hippocampal [3H]-GABA release
Methamidophos treatment produced a reduction in 
stimulated	[3H]-GABA	release	in	slices	obtained	from	the	
cerebral	cortex	compared	with	the	control	(Fig.	1).	This	ef-
fect	was	observed	after	methamidophos	exposure	for	3	and	
6	months	(Fig.	1a–b).	Basal	[3H]-GABA release was not 
modified	in	any	of	the	groups	studied	at	this	time.	However,	
after	9	months,	stimulated	[3H]-GABA	release	was	signifi-
cantly	increased	in	slices	from	the	cerebral	cortex	compared	
with	the	control	group.	At	this	time,	basal	[3H]-GABA re-
lease	did	not	differ	between	the	groups	studied	(Fig.	1c).
On	the	other	hand,	stimulated	[3H]-GABA release in 
hippocampal slices was also decreased by methamidophos 
exposure	 during	 the	 initial	 6	 months	 of	 this	 study	 (Fig.	
2a–b).	However,	at	the	end	of	9	months	of	methamidophos	
treatment,	changes	in	stimulated	[3H]-GABA release were 
observed	at	the	hippocampal	region	(Fig.	2c).	No	differenc-
es	in	basal	[3H]-GABA release were observed at any time 
studied.
Striatal [3H]-DA release
Methamidophos	exposure	for	3	months	resulted	in	an	
insignificant	light	reduction	in	stimulated	[3H]-DA release 
in	slices	obtained	from	the	striatal	region	compared	with	the	
control	group	(Fig.	3a),	whereas,	no	difference	was	observed	
after	6	months	of	methamidophos	exposure	in	stimulated	
[3H]-DA release at the striatum compared with the control 
(Fig.	3b).	Basal	[3H]-DA	release	was	not	modified	in	any	of	
the groups during the study period.
Discussion
Organophosphates	 represent	 a	 group	 of	 compounds	
sharing a similar chemical structure with resulting inhibi-
tion	of	cholinesterase	enzymes.	They	are	also	well	absorbed	
by	all	routes	of	exposure,	including	the	dermal,	respiratory	
and	gastrointestinal	routes.	Their	primary	route	of	toxicity	
is	irreversible	binding	of	phosphate	radicals	to	the	active	
site	of	the	enzyme	AChE.	This	results	in	excess	cholinergic	
stimulation	and	subsequently	the	acute	clinical	effects	seen	
in	poisoning.	Clinical	effects	from	acute	poisoning	can	be	
separated into autonomic nervous system, neuromuscular 
junction, and central nervous system (CNS) categories3.
Fig. 1.	[ 3H]-GABA	release	from	cerebral	cortex	slices	of	mice	exposed	to	methamidophos.	Statistics	are	presented	as	the	
mean	±	SEM	of	six–seven	experiments	(n=1	per	experiment)	with	determinations	duplicated.	Statistically	different	
with respect to the control group (   and  :	p<0.001	and	p<0.05,	respectively).GABA	and	Dopamine	Release	form	Different	Brain	Regions	in	Mice 166
Postnatal	exposure	of	mice	to	insecticide	not	only	led	
to	a	permanent	and	selective	loss	of	dopaminergic	neurons	
but	also	enhanced	the	impact	of	these	insecticides	during	
adulthood relative to developmental-only or adult-only 
treatment8.
Various	parameters	of	neurotransmission	can	be	direct-
ly	affected	by	neurotoxicants;	these	include	the	enzyme(s)	
of	neurotransmitter	synthesis,	the	release	and	uptake	pro-
Fig. 2.	[ 3H]-GABA	release	from	hippocampal	slices	of	mice	exposed	to	methamidophos.	Statistics	are	presented	as	the	mean	±	
SEM	of	six–seven	experiments	(n=1	per	experiment)	with	determinations	duplicated.	Statistically	different	with	respect	to	
the control group (   and  :	p<0.001	and	p<0.05,	respectively).
Fig. 3.	[ 3H]-DA	release	from	striatal	slices	of	mice	exposed	to	methamidophos.	Statistics	are	presented	as	the	mean	±	
SEM	of	six–seven	experiments	(n=1	per	experiment)	with	determinations	duplicated.Noriega-Ortega, Armienta-Aldana, Cervantes-Pompa et al. 167
cesses, the enzyme(s) that metabolizes the neurotransmit-
ter, the receptors and postsynaptic events associated with 
receptor	activation.	Some	neurotoxicants	can	interfere	with	
neurotransmission	 indirectly	 by	 interacting,	 for	 example,	
with energy metabolism, sodium channels or ATPases. Fur-
thermore,	 measured	 alterations	 of	 any	 neurotransmission	
parameter	can	be	the	result	of	neuronal	death	caused	by	a	
cytotoxic	effect	of	the	neurotoxicants.	Thus,	the	decrease	
in	stimulated	GABA	and	DA	release	observed	in	this	work	
was associated with convulsive seizures shown by the mice 
after	 methamidophos	 administration,	 indicating	 reduced	
neurotransmission	as	a	result	of	neuronal	damage	in	the	re-
gion	studied.	A	possible	decrease	in	release	of	GABA	and	
concomitant increase in seizure susceptibility have been 
demostrated	by	blocking	the	GABA-gated	chloride	chan-
nel12.	A	similar	work13 showed that treatment with aldrin, 
an organochlorine insecticide, made rats more susceptible 
to	sound-induced	seizures,	suggesting	the	involvement	of	
both	noradrenergic	and	alteration	excitability	of	the	CNS	
with the observed increments in seizure susceptibility. Fur-
thermore, organophosphoruses owe their acute toxicity to 
inhibition	of	AChE	and	accumulation	of	ACh	at	cholinergic	
receptors. Chronic exposure to these compounds results in 
the	development	of	tolerance	for	their	toxicity,	which	was	
associated	with	a	decrease	in	the	density	of	muscarinic	and	
nicotinic receptors in both the central and peripheral ner-
vous systems14.
These	works	may	suggest	that	developmental	exposure	
to insecticides elicits long-lasting alterations in cell-signal-
ing cascades that are shared by multiple neurotransmitters 
and	hormonal	inputs;	the	resultant	abnormalities	of	synaptic	
communication	are	thus	likely	to	occur	in	widespread	neu-
ral circuits and induce corresponding behaviors9.
The	toxic	actions	of	insecticides	are	due	primarily	to	
their	ability	to	inhibit	AChE,	an	enzyme	responsible	for	the	
breakdown	of	the	neurotransmitter	ACh.	The	result	is	exces-
sive ACh accumulation at synapses, where only small quan-
tities	of	ACh	are	needed	for	transmission.	Agent-induced	
ACh	accumulation	generates	side	effects	that	involve	action	
on other CNS neurotransmitter systems (e.g., norepineph-
rine,	dopamine,	and	γ-amino	butyric	acid).	The	interplay	of	
various neurotransmitters within the nervous system prob-
ably	results	in	these	varied	side	effects15, although nerve 
agents	may	exert	direct	effects	on	these	same	noncholiner-
gic systems16.
Developmental neurotoxicity is concerned with ad-
verse	health	effects	of	exogenous	agents	acting	on	neurode-
velopment. Because human brain development is a delicate 
process	involving	many	cellular	events,	the	developing	fetus	
is rather susceptible to compounds that can alter the struc-
ture	and	function	of	the	brain.	Today,	there	is	clear	evidence	
that early exposure to many neurotoxicants can severely 
damage the developing nervous system. Although, in recent 
years, there has been much attention given to model devel-
opment	and	risk	assessment	procedures	for	developmental	
toxicants,	the	area	of	developmental	neurotoxicity	has	been	
largely	ignored.	Here,	we	consider	the	problem	of	risk	esti-
mation	for	developmental	neurotoxicants	from	animal	bio-
assay	data.	Since	most	responses	from	developmental	neu-
rotoxicity experiments are nonquantal in nature, an adverse 
health	effect	will	be	defined	as	a	response	that	occurs	with	
very small probability in unexposed animals1.
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